The Center for Biologics Evaluation and Research (CBER) is the division of FDA that is responsible for the licensing and regulation of biologic drug products. These are pharmaceuticals that have biologic systems as their origin, such as vaccines, blood products and genetically engineered formulations.
Glossary
Center for Biologics Evaluation and Research (CBER)
Resources
Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.
Glossary
The Life Sciences glossary with terminology, acronyms, for regulatory, quality, compliance, clinical trials, and pharmacovigilance software.
Found 371 Results
Page 1 of 2
Page 1 of 2
Page 1 of 2
Page 1 of 2